ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Sacituzumab Tirumotecan(Sac-TMT) and Brain Radotherapy for EGFR+ NSCLC With Brain Mets

Xiaorong Dong · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
non-small-cell-lung-cancer
non-small cell lung cancer, brain metastases from non-small cell lung cancer (nsclc), egfr mutation positive advanced non-small cell lung cancer, sacituzumab tirumotecan(sac-tmt/skb264)、brain radiotherapy、egfr-tki resistance、intracranial progression-free survival, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 875961
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.